XOMA 129
XOMA 129 is a human monoclonal antibody targeting INSR. XOMA 129 is an insulin receptor (IR) antagonist that inhibits the drop in blood glucose. XOMA 129 can be used in the study of hypoglycemia [1].
Product Specifications
UNSPSC
12352203
Target
Insulin Receptor
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Endocrinology
Smiles
[XOMA129]
References & Citations
[1]Li O, et al. XOMA 129, a Novel Insulin Receptor Negative Modulator, Is Efficacious in Treating Insulin-Induced Hypoglycemia in Minipigs[J]. Blood, 2017, 200 (100) : 0.
Shipping Conditions
Room temperature
Scientific Category
Inhibitory Antibodies
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC940680-500 1x 500 µL
Cyclin B1 (V92.1), CF594 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470741-500 1x 500 µL
Prolactin Receptor (B6.2), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details